Craig A. Waldman

Waldman represents companies in antitrust government investigations and enforcement actions, merger reviews and counseling and antitrust private litigation. He has worked across many industries such as information technology hardware and software, electronic design automation, health care and financial institutions.

His background includes a stint from 1993 to 1996 at the Federal Trade Commission’s Mergers I division. There he was involved in high-profile investigations including Rite Aid Corp.’s attempted acquisition of Revco, Lockheed Corp.’s purchase of Martin Marietta Corp., First Financial Management Corp.’s merger with First Data and Glaxo PLC’s acquisition of Wellcome.

“There are plenty of very fine antitrust lawyers who have never spent a day in the agency, but I do think my time at the FTC provides an insight into which are the right battles to pick,” he said.

This year he represented Linear Technology before the FTC in its sale to Analog Devices Inc. for $14.8 billion and coordinated the global defense of the transaction before several foreign jurisdictions. “There has been a lot of consolidation in the semiconductor industry,” he said. “At Jones Day, we are an organization with a worldwide capability to get deals done. It certainly helps a lot to have a ton of offices around the world with strong local antitrust practices.”

Waldman has been lead counsel for multiple companies for confidential investigations before the FTC and the U.S. Department of Justice involving issues of boycott, no-poach agreement violations and other potentially collusive behavior.

He was lead attorney in Jones Day’s role advising Wabtec Corp. in its offer to acquire Faiveley Transport S.A., a leading global provider of integrated systems and services for the railway industry, for $1.8 billion in cash and stock. Waldman’s task included representing Wabtec throughout a lengthy review by the DOJ and close coordination with the EU antitrust authorities.

Among his most recent blockbuster deals: representing Reynolds American Inc. in its sale to British American Tobacco Plc for $49 billion. “This deal and the prior $27 billion Reynolds purchase of Lorillard were mega-deals,” he said.

— John Roemer